235 related articles for article (PubMed ID: 17589947)
1. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease.
Meijer MJ; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Hommes DW; Verspaget HW
World J Gastroenterol; 2007 Jun; 13(21):2960-6. PubMed ID: 17589947
[TBL] [Abstract][Full Text] [Related]
2. Effect of the anti-tumor necrosis factor-alpha antibody infliximab on the ex vivo mucosal matrix metalloproteinase-proteolytic phenotype in inflammatory bowel disease.
Meijer MJ; Mieremet-Ooms MA; van Duijn W; van der Zon AM; Hanemaaijer R; Verheijen JH; van Hogezand RA; Lamers CB; Verspaget HW
Inflamm Bowel Dis; 2007 Feb; 13(2):200-10. PubMed ID: 17206679
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and their tissue inhibitors as prognostic indicators for diagnostic and surgical recurrence in Crohn's disease.
Meijer MJ; Mieremet-Ooms MA; Sier CF; van Hogezand RA; Lamers CB; Hommes DW; Verspaget HW
Inflamm Bowel Dis; 2009 Jan; 15(1):84-92. PubMed ID: 18634035
[TBL] [Abstract][Full Text] [Related]
4. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa.
Arai T; Kakuta Y; Kinouchi Y; Kimura T; Negoro K; Aihara H; Endo K; Shiga H; Kanazawa Y; Kuroha M; Moroi R; Nagasawa H; Shimodaira Y; Takahashi S; Shimosegawa T
Hum Immunol; 2011 Jul; 72(7):587-91. PubMed ID: 21514341
[TBL] [Abstract][Full Text] [Related]
6. [Tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease].
Kim TH; Kim BG; Shin HD; Kim JW; Kim CG; Kim JS; Jung HC; Song IS
Korean J Gastroenterol; 2003 Nov; 42(5):377-86. PubMed ID: 14646574
[TBL] [Abstract][Full Text] [Related]
7. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
[TBL] [Abstract][Full Text] [Related]
9. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor-alpha (-308G/A) promoter polymorphism is associated with ulcerative colitis in Brazilian patients.
Tavares M; de Lima C; Fernandes W; Martinelli V; de Lucena M; Lima F; Telles A; Brandão L; de Melo Júnior M
Int J Immunogenet; 2016 Dec; 43(6):376-382. PubMed ID: 27528546
[TBL] [Abstract][Full Text] [Related]
11. Correlation between a gene polymorphism of tumor necrosis factor and inflammatory bowel disease.
Song Y; Wu KC; Zhang L; Hao ZM; Li HT; Zhang LX; Qiao TD; Li CN; Fan DM
Chin J Dig Dis; 2005; 6(4):170-4. PubMed ID: 16246225
[TBL] [Abstract][Full Text] [Related]
12. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
13. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
15. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
[TBL] [Abstract][Full Text] [Related]
16. TNF-857 polymorphism in Israeli Jewish patients with inflammatory bowel disease.
Fidder HH; Heijmans R; Chowers Y; Bar-Meir S; Avidan B; Pena AS; Crusius JB
Int J Immunogenet; 2006 Apr; 33(2):81-5. PubMed ID: 16611251
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk.
Ferguson LR; Huebner C; Petermann I; Gearry RB; Barclay ML; Demmers P; McCulloch A; Han DY
World J Gastroenterol; 2008 Aug; 14(29):4652-61. PubMed ID: 18698679
[TBL] [Abstract][Full Text] [Related]
18. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
19. Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.
Muro M; López-Hernández R; Mrowiec A
World J Gastroenterol; 2014 Nov; 20(41):15037-48. PubMed ID: 25386052
[TBL] [Abstract][Full Text] [Related]
20. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
